219 related articles for article (PubMed ID: 35956844)
1. Metagenomics Approach to the Intestinal Microbiome Structure and Abundance in High-Fat-Diet-Induced Hyperlipidemic Rat Fed with (-)-Epigallocatechin-3-Gallate Nanoparticles.
Chen Z; Liu B; Gong Z; Huang H; Gong Y; Xiao W
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956844
[TBL] [Abstract][Full Text] [Related]
2. Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota.
Wen JJ; Li MZ; Chen CH; Hong T; Yang JR; Huang XJ; Geng F; Hu JL; Nie SP
Food Chem; 2023 Mar; 404(Pt A):134591. PubMed ID: 36444016
[TBL] [Abstract][Full Text] [Related]
3. Controlled release and antioxidant activity of chitosan and β-lactoglobulin complex nanoparticles loaded with epigallocatechin gallate.
Dai W; Ruan C; Sun Y; Gao X; Liang J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110802. PubMed ID: 31958618
[TBL] [Abstract][Full Text] [Related]
4. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage.
Avadhani KS; Manikkath J; Tiwari M; Chandrasekhar M; Godavarthi A; Vidya SM; Hariharapura RC; Kalthur G; Udupa N; Mutalik S
Drug Deliv; 2017 Nov; 24(1):61-74. PubMed ID: 28155509
[TBL] [Abstract][Full Text] [Related]
5. Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic
Park JM; Shin Y; Kim SH; Jin M; Choi JJ
J Med Food; 2020 Oct; 23(10):1033-1042. PubMed ID: 33054538
[TBL] [Abstract][Full Text] [Related]
6. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Santana A; Santamarina A; Souza G; Mennitti L; Okuda M; Venancio D; Seelaender M; do Nascimento CO; Ribeiro E; Lira F; Oyama L
J Nutr Biochem; 2015 Sep; 26(9):893-902. PubMed ID: 26048201
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice.
Ushiroda C; Naito Y; Takagi T; Uchiyama K; Mizushima K; Higashimura Y; Yasukawa Z; Okubo T; Inoue R; Honda A; Matsuzaki Y; Itoh Y
J Clin Biochem Nutr; 2019 Jul; 65(1):34-46. PubMed ID: 31379412
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and releasing property of antibacterial nano-capsules composed of ε-PL-EGCG and sodium alginate-chitosan.
Li W; Li W; Wan Y; Wang L; Zhou T
Int J Biol Macromol; 2022 Apr; 204():652-660. PubMed ID: 35093440
[TBL] [Abstract][Full Text] [Related]
9. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
[TBL] [Abstract][Full Text] [Related]
10. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
[TBL] [Abstract][Full Text] [Related]
12. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
13. EGCG Prevents High Fat Diet-Induced Changes in Gut Microbiota, Decreases of DNA Strand Breaks, and Changes in Expression and DNA Methylation of
Remely M; Ferk F; Sterneder S; Setayesh T; Roth S; Kepcija T; Noorizadeh R; Rebhan I; Greunz M; Beckmann J; Wagner KH; Knasmüller S; Haslberger AG
Oxid Med Cell Longev; 2017; 2017():3079148. PubMed ID: 28133504
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
15. The effect of EGCG/tyrosol-loaded chitosan/lecithin nanoparticles on hyperglycemia and hepatic function in streptozotocin-induced diabetic mice.
Es-Haghi A; Soltani M; Tabrizi MH; Noghondar MK; Khatamian N; Naeeni NB; Kharaghani M
Int J Biol Macromol; 2024 May; 267(Pt 2):131496. PubMed ID: 38626839
[TBL] [Abstract][Full Text] [Related]
16. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
Pandit AP; Joshi SR; Dalal PS; Patole VC
BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.
Dey P; Olmstead BD; Sasaki GY; Vodovotz Y; Yu Z; Bruno RS
J Nutr Biochem; 2020 Oct; 84():108455. PubMed ID: 32688217
[TBL] [Abstract][Full Text] [Related]
18. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
[TBL] [Abstract][Full Text] [Related]
19. Effect of EGCG on lipid absorption and plasma lipid levels in rats.
Raederstorff DG; Schlachter MF; Elste V; Weber P
J Nutr Biochem; 2003 Jun; 14(6):326-32. PubMed ID: 12873714
[TBL] [Abstract][Full Text] [Related]
20. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
Frias I; Neves AR; Pinheiro M; Reis S
Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
